High River

High River Pharmaceuticals is a specialty pharmaceutical company and a wholly-owned subsidiary of Lupin Limited, a global pharmaceutical leader. Based in Somerset, New Jersey, the company serves as a strategic vehicle for Lupin's expansion into the United States specialty and generic drug markets. High River Pharmaceuticals is primarily involved in the commercialization and distribution of a diverse portfolio of generic medications across various therapeutic areas, including pain management and gastrointestinal health. The entity gained significant prominence through its role in Lupin's acquisition of Gavis Pharmaceuticals, which substantially bolstered the parent company's manufacturing footprint and product pipeline in the U.S. market.